Published in Health Business Week, June 26th, 2009
Relapsed Multiple Myeloma Patients Achieve Responses with Single-Agent Carfilzomib
Keith Stewart, M.B., Ch.B., Professor, Division of Hematology/Oncology at the Mayo Clinic, Arizona presented positive data from an ongoing Phase 2 clinical trial of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week